Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

The emerging roles of SUMOylation in pulmonary diseases

Role and mechanism of post-translational SUMOylation in atherosclerosis

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

[Sumoylation and Its Role in Hematological Disease].

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

SUMOylation: A Link to Future Therapeutics.

SUMO: A new perspective to decipher fibrosis

Protein SUMOylation Modification and Its Associations with Disease

The Emerging Roles of SUMOylation in the Tumor Microenvironment and Therapeutic Implications

The role and mechanism of SUMO modification in liver disease

Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.

SUMOylation at the crossroads of gut health: insights into physiology and pathology

Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease

Signalling mechanisms and cellular functions of SUMO

SUMOylation Homeostasis in Tumorigenesis

Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases

Tissue Adaptation to Metabolic Stress: Insights from SUMOylation

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Sumoylation As an Emerging Target in Therapeutics Against Cancer